Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

GALNT14 gene

Known as: UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 14, polypeptide N-acetylgalactosaminyltransferase 14, polypeptide GalNAc transferase 14 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Some polypeptide N-acetyl-galactosaminyltransferases (GALNTs) are associated with cancer, but their function in organ-specific… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2016
2016
AIM Transcatheter arterial chemoembolization is currently the standard treatment in hepatocellular carcinoma patients with… Expand
Is this relevant?
2016
2016
Increasing evidence has suggested that dysregulation of microRNAs (miRNAs) could contribute to tumor progression. The miR-125a… Expand
Is this relevant?
2015
2015
Although several genes have been associated to neuroblastoma (NB) predisposition and aggressiveness, further genes are likely… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2015
2015
Aberrant glycosylation is a hallmark of most human cancers and affects many cellular properties, including cell proliferation… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2014
2014
A GALNT14 single nucleotide polymorphism, rs9679162, has recently been found to be capable of predicting chemotherapy responses… Expand
  • table I
  • table II
  • figure 1
  • table III
  • figure 2
Is this relevant?
2014
2014
In addition to targeted agents, chemotherapy is currently considered to be a treatment option for patients with advanced… Expand
  • table I
  • table II
  • table II
  • table III
  • table IV
Is this relevant?
2013
2013
A high expression of O-glycosylated proteins is one of the prominent characteristics of ovarian carcinoma cells associated with… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2011
2011
AIM Despite the availability of targeted anticancer agents, combination chemotherapy remains an option for patients with far… Expand
Is this relevant?
2010
2010
PURPOSE In vitro sensitivity to the proapoptotic receptor agonists dulanermin (rhApo2L/TRAIL) and drozitumab (DR5-agonist… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?